EUVIMEDEUVIMED entdecken
Crossref

The management of non‐culprit vessel(s) in patients with unstable angina/ non‐ST elevation myocardial infarction and chronic kidney dysfunction

Guang-Zhi Liao iD, Yi-Ming Li, Ting Liu, Lin Bai, Xue-Feng Chen, Yu-Yang Ye, Hua Chai, Yong Peng iD

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Guang-Zhi Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, Scientific Research Project of Sichuan Provincial Health Commission (Key Project), Sichuan Provincial Cadre Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The clinical effects of multivessel interventions in patients with unstable angina/non‐ST‐segment elevation myocardial infarction (UA/NSTEMI), multivessel disease (MVD) and chronic kidney disease (CKD) remain uncertain. This study aimed to investigate the safety and effectiveness of intervention in non‐culprit lession(s) among this cohort.

Methods

We consecutively included patients diagnosed with UA/NSTEMI, MVD and CKD between January 2008 and December 2018 at our centre. After successful percutaneous coronary intervention (PCI), we compared 48‐month overall mortality between those undergoing multivessel PCI (MV‐PCI) through a single‐procedure or staged‐procedure approach and culprit vessel‐only PCI (CV‐PCI) after 1:1 propensity score matching. We conducted stratified analyses and tests for interaction to investigate the modifying effects of critical covariates. Additionally, we recorded the incidence of contrast‐induced nephropathy (CIN) to assess the perioperative safety of the two treatment strategies.

Results

Of the 749 eligible patients, 271 pairs were successfully matched. Those undergoing MV‐PCI had reduced all‐cause mortality (hazard ratio (HR): 0.67, 95% confidence interval (CI): 0.48–0.67). Subgroup analysis showed that those with advanced CKD (estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/1.73 m 2 ) could not benefit from MV‐PCI ( P = 0.250), and the survival advantage also tended to diminish in diabetes ( P interaction < 0.01; HR = 0.95, 95% CI = 0.65–1.45). Although the staged‐procedure approach ( N = 157) failed to bring additional survival benefits compared to single‐procedure MV‐PCI ( N = 290) ( P = 0.460), it showed a tendency to decrease the death risk. CIN risks in MV‐PCI and CV‐PCI groups were not significantly different (risk ratio = 1.60, 95% CI = 0.94–2.73).

Conclusion

Among patients with UA/NSTEMI and non‐diabetic CKD and an eGFR > 30 mL/min/1.73 m 2 , MV‐PCI was associated with a reduced risk of long‐term death but did not increase the incidence of CIN during the management of MVD compared to CV‐PCI. And staged procedures might be a preferable option over single‐procedure MV‐PCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePercutaneous Coronary InterventionNon-ST Elevated Myocardial InfarctionST Elevation Myocardial InfarctionRenal Insufficiency, ChronicHumansAngina, UnstableKidneyTreatment Outcome

Stichwörter der Autor:innen

UA/NSTEMIchronic kidney dysfunctionmultivessel diseasemultivessel interventionspercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Academic Affairs, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Guang-Zhi Liao, Yong Peng

Förderung

  • 1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University
  • Scientific Research Project of Sichuan Provincial Health Commission (Key Project)
  • Sichuan Provincial Cadre Health Research Project
  • Sichuan Science and Technology Programme

Zitieren

APA

Liao, G. Z., Li, Y. M., Liu, T., Bai, L., Chen, X. F., Ye, Y. Y., Chai, H., & Peng, Y. (2024). The management of non‐culprit vessel(s) in patients with unstable angina/ non‐ST elevation myocardial infarction and chronic kidney dysfunction. Internal Medicine Journal. https://doi.org/10.1111/imj.16201

Vancouver

Liao GZ, Li YM, Liu T, Bai L, Chen XF, Ye YY, et al. The management of non‐culprit vessel(s) in patients with unstable angina/ non‐ST elevation myocardial infarction and chronic kidney dysfunction. Internal Medicine Journal. 2024. doi:10.1111/imj.16201

BibTeX
@article{Liao2024,
  author = {Liao, Guang-Zhi and Li, Yi-Ming and Liu, Ting and Bai, Lin and Chen, Xue-Feng and Ye, Yu-Yang and Chai, Hua and Peng, Yong},
  title = {The management of non‐culprit vessel(s) in patients with unstable angina/ non‐ST elevation myocardial infarction and chronic kidney dysfunction},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16201}
}
Kostenlos starten →